Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Private Equity Compliance Checklist

The complex and ever-changing healthcare regulatory and enforcement environment, including increased focus on the role of private equity firms in their portfolio companies, make compliance a top priority for private equity firms investing in healthcare companies. The best way to limit your exposure as a private equity firm is to avoid a compliance misstep in the first place. Additionally, an effective and robust compliance program for your portfolio healthcare company makes it much more attractive to potential buyers and helps you avoid an unexpected and costly investigation or valuation hit down the road. Download the Healthcare Private Equity Compliance Checklist to assess whether your portfolio company's compliance program is up-to-date.

Click here to download the checklist.

Bass, Berry & Sims Recommended Firm for M&A – Middle-Market (sub-$500M) by The Legal 500 United States 2016

June 24, 2016

Bass, Berry & Sims was recommended as a United States firm for "M&A – Middle-Market (sub-$500M)" by The Legal 500 United States 2016 guide. The 10th annual edition of The Legal 500 United States compiled research from law firms, peers and clients nationwide to recommend the top law firms in various categories. According to the guide:

Bass, Berry & Sims PLC has particularly strong government contractor and healthcare M&A practices. The team assisted Engility Holdings with its acquisition of TASC, advised Gen Cap America on its acquisition of Aero Systems Engineering, and acted for Emergent BioSolutions in the government contract aspects of its acquisition of assets relating to a contract with the Defense Threat Reduction Agency. In the healthcare space, it advised Little Hills Healthcare on its sale to CenterPointe Behavioral Health System, and acted for Healthways in its disposition of Navvis Healthcare. Todd Overman in Washington DC is chair of the firm's government contracts practice and has more than a decade of experience advising companies on doing business with the federal government. Nashville-based Riney Green has 25 years-plus experience in guiding middle-market companies and private equity sponsors through M&A, dispositions and other strategic growth initiatives, and provides M&A and corporate governance counsel to a publicly traded long-term care company. Allen Overby, also in Nashville, focuses mainly on public company M&A transactions in the $50m-$1bn range, with an emphasis on cross-border M&A and strategic transactions.

To read more about the recognition, please visit The Legal 500 United States website.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.